My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Chronic hepatitis B virus infection: treatment strategies for the next millennium.

    Malik AH, Lee WM.

    Ann Intern Med. 2000 May 2;132(9):723-31. Review.PMID: 10787366 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Management of viral hepatitis B.

    Pramoolsinsup C.

    J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.PMID: 12000599 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment of chronic hepatitis B: case selection and duration of therapy.

    Leung N.

    J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.PMID: 11982721 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of chronic hepatitis B.

    Yuen MF, Lai CL.

    Lancet Infect Dis. 2001 Nov;1(4):232-41. Review.PMID: 11871510 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical potential of emerging new agents in hepatitis B.

    Farrell GC.

    Drugs. 2000 Oct;60(4):701-10. Review.PMID: 11085196 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Influence of a triplex superimposed treatment on HBV replication and mutation during treating chronic hepatitis B]

    Wu L, Liu H, Xue P, Lu ZG, Du KF.

    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Sep;15(3):236-8. Chinese. PMID: 11986694 [PubMed - indexed for MEDLINE]Related articles

    7.

    A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

    Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ.

    Ann Intern Med. 2005 Feb 15;142(4):240-50.PMID: 15710957 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.

    Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ.

    J Med Virol. 2007 Nov;79(11):1650-4.PMID: 17854040 [PubMed - indexed for MEDLINE]Related articles

    9.

    The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro.

    Delaney WE 4th, Yang H, Westland CE, Das K, Arnold E, Gibbs CS, Miller MD, Xiong S.

    J Virol. 2003 Nov;77(21):11833-41.PMID: 14557667 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.

    Perrillo R, Hann HW, Mutimer D, Willems B, Leung N, Lee WM, Moorat A, Gardner S, Woessner M, Bourne E, Brosgart CL, Schiff E.

    Gastroenterology. 2004 Jan;126(1):81-90.PMID: 14699490 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B.

    Kaymakoglu S, Oguz D, Gur G, Gurel S, Tankurt E, Ersöz G, Ozenirler S, Kalayci C, Poturoglu S, Cakaloglu Y, Okten A.

    Antimicrob Agents Chemother. 2007 Aug;51(8):3020-2. Epub 2007 May 21.PMID: 17517832 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

    Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM.

    Ann Intern Med. 2005 May 17;142(10):821-31.PMID: 15897532 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Profound suppression of hepatitis B virus replication with lamivudine.

    Lai CL, Yuen MF.

    J Med Virol. 2000 Jul;61(3):367-73. Review.PMID: 10861648 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.

    Guptan RC, Thakur V, Kazim SN, Sarin SK.

    J Gastroenterol Hepatol. 2002 Jul;17(7):765-71.PMID: 12121506 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.

    Leemans WF, Flink HJ, Janssen HL, Niesters HG, Schalm SW, de Man RA.

    J Hepatol. 2006 Mar;44(3):507-11. Epub 2006 Jan 19.PMID: 16457904 [PubMed - indexed for MEDLINE]Related articles

    16.

    Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.

    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.

    J Med Virol. 2007 Nov;79(11):1664-70.PMID: 17854034 [PubMed - indexed for MEDLINE]Related articles

    17.

    A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.

    Mazur W, Król F, Cianciara J, Nazzal K, Gładysz A, Juszczyk J, Bolewska B, Adamek J, Czajka B, Swietek K, Kryczka W, Gonciarz Z.

    Med Sci Monit. 2002 Apr;8(4):CR257-62.PMID: 11951067 [PubMed - indexed for MEDLINE]Related articles

    18.

    A 3-year clinical trial of lamivudine in treatment of patients with chronic hepatitis B.

    Yao GB, Cui ZY, Wang BE, Yao JL, Zeng MD.

    Hepatobiliary Pancreat Dis Int. 2004 May;3(2):188-93.PMID: 15138107 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Occurrence and predictive factors of hepatitis B virus polymerase YMDD variation among patients with chronic hepatitis B and liver cirrhosis during lamivudine therapy]

    Wang L, Yan J, Zhang ZH, Wang JB, Du YZ, Li XY, Wang YZ.

    Zhonghua Gan Zang Bing Za Zhi. 2004 Oct;12(10):585-8. Chinese. PMID: 15504286 [PubMed - indexed for MEDLINE]Related articles

    20.

    A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection.

    Zoulim F.

    Drug Saf. 2002;25(7):497-510. Review.PMID: 12093308 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity